Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Scion Joins Covid-19 Vaccine Corporation’s Effort To Make NZ Own Covid Vaccine Via Unique Local Tech

Scion has partnered with New Zealand’s most experienced group of vaccine producers in the effort to produce a Covid-19 vaccine in New Zealand, for New Zealanders and the world.

Scion’s biotechnology pilot plant is critical to Covid-19 Vaccine Corporation’s vaccine development. The facility will allow CVC to grow its vaccine-producing bacteria at scale, making vaccine materials for testing purposes.

“Working with Scion will allow CVC to accelerate development and put us on a fast-track towards manufacturing and testing our Covid-19 vaccine. We really appreciate how Dr Lloyd-Jones’ team and Scion have moved to expedite our work; it’s another example of Kiwis pulling together and doing what they can to fight this dangerous disease,” says CVC’s Chief Scientific Officer, Dr Andy Herbert.

clockwise from front left: Taryn Saggese (Scion), Gareth Lloyd-Jones (Scion), David Hooks (Scion), Christophe Collet (Scion),  Andy Hollings (CVC), Alyesha Candy (Scion), Mark West (Scion), Sumanth Ranganathan (Scion)

CVC’s intended vaccine differs from other vaccine candidates for its unique biobead technology that it licensed from New Zealand company, Polybatics. It is currently working towards making small volumes of these vaccine-producing bacteria at the University of Auckland.

Its method includes making biobeads coated with carefully chosen components of the SARS-Cov-2 virus. The biobeads and coating are simultaneously manufactured inside bacteria which is an efficient method of production for a vaccine that the company expects to be both safe while offering broad immune coverage in humans.

These biobeads are grown at scale and purified at Scion’s specialised facility, where they will be produced as a test vaccine suitable for various testing purposes.

“Scion is delighted to assist in the development of CVC’s COVID-19 vaccine. With our fermentation capability and expertise in producing customised biopolymers, the Scion team will be able to produce vaccine materials for preclinical testing.”

“Scion has experience in producing bioplastic materials that are the main component of Polybatics’ biobeads technology that CVC is adapting for vaccine production,” says Dr Gareth Lloyd-Jones, Science Leader Biotransformation at Scion.

If testing is successful, CVC will manufacture more biobead vaccines for human trials using Good Manufacturing Practice, which requires stringent and traceable protocols.

CVC’s partners include the University of Auckland, Fonterra, Callaghan Innovation, Ardigen, and now Scion.

ABOUT CVC

CVC is made up of a group of lifelong biotech experts:

Dr Robert Feldman - a serial biotech entrepreneur and medical doctor with vaccine experience.

Dr Andy Herbert - a pharmaceutical development and manufacturing expert.

Tara Creaven-Capasso - a regulatory, quality and biotech expert with extensive international experience.

Helen Teale - a global clinical trial management expert.

Jeff Douglas – Managing director of Douglas Pharmaceuticals.

To date, the company has raised a million dollars in private company funding, and $488,000 in government funding.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 




Greenpeace: Calls Foul On INEOS Rugby Sponsorship Deal

Greenpeace is calling foul on NZ Rugby’s decision to sign a sponsorship deal with the oil and plastic polluting petrochemical giant INEOS. "In the thick of the climate crisis, it’s gutting to see NZ Rugby sign a sponsorship deal with an oil and gas polluting conglomerate... More>>



Stats NZ: Quarterly Inflation Rising Steadily Across The Board

Higher prices for transport and food have driven up inflation for the all households group in the June 2021 quarter, Stats NZ said today. The ‘all households group’ represents all private New Zealand-resident households... More>>


Stats NZ: Primary Products Push Exports To A New High

New Zealand exports reached a new high in June 2021, off the back of record export values for logs and beef, Stats NZ said today. In June 2021, the value of all goods exports rose... More>>


Real Estate: June Home Transfers Remain High
There were 44,517 home transfers in the June 2021 quarter, the highest June quarter figure since 2016, Stats NZ said today. The number of home transfers was very similar to the March 2021 quarter and was up 18,252 from the June 2020 quarter... More>>



Statistics: Household Saving Falls In The March 2021 Quarter

Saving by New Zealanders in the March 2021 quarter fell to its lowest level in two years after rising sharply in 2020, Stats NZ said today. Increases in household spending outpaced income growth, leading to a decline in household saving from the elevated levels that prevailed throughout 2020... More>>

ALSO: